一本关于管理护理药房药房临床计划的入门书
1Curricular Affairs and Accreditation, College of Pharmacy, University of Florida, Gainesville.
临床药房计划对于安全,有效和负担得起的药物使用至关重要. 本书详细介绍了管理护理组织的计划设计,实施和评估策略,以改善患者的治疗结果.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 药房实践 在药房实践.
- 管理护理管理护理
背景情况:
- 临床药房计划是管理护理药房的基础.
- 这些计划确保安全,有效和具有成本效益的药物使用.
- 它们对于改善不同人群的患者结果至关重要.
研究的目的:
- 提供临床药房课程类型的全面概述.
- 概述这些计划的设计,实施和评估的策略.
- 突出临床药学中的关键目标,当前趋势和基于价值的调整.
主要方法:
- 文献审查和现有实践的综合.
- 分析各种医疗保健机构的程序结构.
- 确定程序开发和执行的最佳实践.
主要成果:
- 多种临床药房计划模型的分类.
- 计划设计,推广和评估的详细策略.
- 重点是使计划目标与基于价值的医疗保健原则保持一致.
结论:
- 临床药房计划对于优化药物管理是不可或缺的.
- 有效的计划设计和实施是实现所需健康结果的关键.
- 基于价值的调整对于临床药房倡议的长期成功和影响至关重要.
更多相关视频
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
10:45A Community-based Stress Management Program: Using Wearable Devices to Assess Whole Body Physiological Responses in Non-laboratory Settings
Published on: January 22, 2018
相关概念视频
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Acute Pancreatitis II: Clinical Manifestations and Management
